Related Experiment Video
Updated: May 16, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
RETRACTION: Enhancing Wound Healing and Overcoming Cisplatin Resistance in Ovarian Cancer
Retraction:
Q. Zhang, F. Guo, H. Liu, and L. Hong, "Enhancing Wound Healing and Overcoming Cisplatin Resistance in Ovarian Cancer," International Wound Journal 21, no. 4 (2024): e14569, https://doi.org/10.1111/iwj.14569. The above article, published online on 29 December 2023, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our notice regarding the retraction.
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

